Local Ablative Treatments for Liver Metastases: The Current Situation

References

• Fong Y., Cohen A. M., Fortner J. G. et al. Liver resection for colorectal liver metastases. J Oncol, 1997, 15: 938–46.
   Google Scholar
• Jenkins L. T., Milikan K. W., Bines S. D. et al. Hepatic resection for metastatic colorectal cancer. Am Surg, 1997, 63: 605–13.
   Google Scholar
• Minagawa M., Makuuchi M., Torzilli G. et al. Extension of the frontiers of surgical indications in the treatment of liver metasta-ses from colorectal cancer. Ann Surg, 2000, 231: 487–99.
   Google Scholar
• Wanebo H. J., Semoglou C., Attiyeh F. et al. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg, 1978, 135: 81–5.
   Google Scholar
• Douillard J. Y., Cunningham D., Roth A. D. Iotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial. Lancet, 2000, 355: 1041–7.
   Google Scholar
• Malafosse R., Penna C., Cunha A. S. et al. Surgical management of hepatic metastases from colorectal cancer. J Surg Oncol, 2001, 12: 887–94.
   Google Scholar
• Fiorentini G., Poddie D. B., Cantore M. et al. Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology, 2001, 48: 305–12.
   Google Scholar
• Kemeny N., Gonen M., Sullivan D. et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol, 2001, 19: 2687–95.
   Google Scholar
• Bloomstom M., Binitie O., Fraiji E. et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg, 2002, 68: 827–31.
   Google Scholar
• Giovannini M., Seitz J. F. Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer, 1994, 73: 297–7.
   Google Scholar
• Giovannini M. Percutaneous alcohol ablation for liver metastasis. Sem Oncol, 2002, 29:, 192–5.
   Google Scholar
• Kurokohchi K., Watanabe S., Masaki T. et al. Combined therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int J Oncol, 2002, 21: 611–5.
   Google Scholar
• Seifert J. K., Morris D. L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg, 1999, 23: 109–13.
   Google Scholar
• Pearson A. S., Izzo F., Fleming R. Y. D. et al. Intraoperative radio-frequency ablation or cryoablation for hepatic malignancies.Am J Surg, 1999, 178: 592–9.
   Google Scholar
• Bilchik A. J., Wood T. F., Allegra D. P. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist, 2001, 6: 24–33.
   Google Scholar
• Curley S. A., Izzo F., Ellis L. et al. Radiofrequency ablation of unresctable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg, 1999, 230: 1–8.
   Google Scholar
• Curley S. A. Radiofrequency ablation of malignant liver tumors. Oncologist, 2001, 6: 14–23.
   Google Scholar
• Mulier S., Mulier P., Ni Y. et al. Complications of radiofrequency coagulation of liver tumors. Br J Surg, 2002, 89: 1206–22.
   Google Scholar
• Shafir M., Shapiro R., Sung M. Cryoablation of unresectable malignant liver tumors. Am J Surg, 1996, 171: 156–62.
   Google Scholar
• Scheele J., Stang R., Altendorf-Hofman A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg, 1990, 77: 1241–6.
   Google Scholar
• Meta J., Seltzer M., Schiepers C. et al. Impact of (18)F-FDG PET on managing patients with colorectal cancer: the referring physician’s perspective. J Nucl Med, 2001, 42: 586–90.
   Google Scholar
• Tsuda M., Majima K., Yamada T. et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging, 2001, 25 409–15.
   Google Scholar
• Chopra S., Dodd G. D. 3rd, Chintapalli K. N. et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrasted-enhanced CT. AJR Am J Roentgenol, 2001, 177: 381–7.
   Google Scholar
• Solbiati L., Ierace T., Tonolini M. et al. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound, 2001, 18: 14958.
   Google Scholar
• Castaing D., Emond J., Kunstlinger F., Bismuth H. Utility of operative ultrasound in the management of liver tumorsAnn Surg, 1996, 204: 600–5.
   Google Scholar
• Wallace J. R., Christians K. K., Quiroz F. A., Foley W. D., Pitt H. A., Quebbeman E. J. Ablation of liver metastasis: is preoperative imaging sufficiently accurate? J Gastrointest Surg, 2001, 5: 98–107.
   Google Scholar
• Tait I. S., Yong S. M., Cuscheiri S. A. Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg, 2002, 89: 1613–9.
   Google Scholar
• Cheng J., Glasgow R. E., O’Rourke R. W., Swanstrom L. L., Hansen P. D. Laparoscopic radiofrequency ablation and hepatic artery infusion pump placement in the evolving treatment of colorectal hepatic metastases. Surg Endosc, 2003, 17: 61–7.
   Google Scholar
• Elias, De Baere T., Smayra T. et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumor recurrence after hepatectomy.Br J Surg, 2002, 89: 752–6.
   Google Scholar
• Elias D., El Ottomany A., Goharin A., Attalah D., De Baere T. How I do it: intraductal cooling of the main bile duct during intraoperative radiofrequency ablation. J Surg Oncol, 2001, 76: 297300.
   Google Scholar
• Langenhoff B. S., Oyen W. J. G., Jager G. J. et al. Efficacy of Fluorine-18-Deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol, 2002, 20: 4453–8.
   Google Scholar
• Hoffman A. L., Wu S. S., Obaid A. K. et al. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors. Am Surg, 2002, 68: 1038–43.
   Google Scholar
• Maziotti A., Grazi G. L., Gardini A. et al. An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg, 1998, 4: 271–5.
   Google Scholar
• De Sio I., Castellano L., De Girolamo V. et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology, 2001, 34: 608–10.
   Google Scholar
• Llovet J. M., Vilana R., Bru C. et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepato-cellular carcinoma. Hepatology, 2001, 33: 1124–9.
   Google Scholar